We are live on ! Find out more

280 hedge funds and large institutions have $4.59B invested in RXO in 2024 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 106 increasing their positions, 55 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

338% more call options, than puts

Call options by funds: $4.83M | Put options by funds: $1.1M

177% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 22

93% more repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 55

46% more capital invested

Capital invested by funds: $3.14B → $4.59B (+$1.44B)

16% more funds holding

Funds holding: 242280 (+38)

1.58% more ownership

Funds ownership: 102.19%103.77% (+1.6%)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

Holders
280
Holders Change
+38
Holders Change %
+15.7%
% of All Funds
4.02%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
61
Increased
106
Reduced
55
Closed
22
Calls
$4.83M
Puts
$1.1M
Net Calls
+$3.73M
Net Calls Change
+$17.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Simplex Trading
151
Simplex Trading
Illinois
$316K +$319K +11,294 New
OSAM
152
O'Shaughnessy Asset Management
Connecticut
$312K +$297K +10,515 New
SIM
153
Sandia Investment Management
Massachusetts
$308K +$311K +11,000 New
Stifel Financial
154
Stifel Financial
Missouri
$301K -$1.98K -70 -0.6%
Cambridge Investment Research Advisors
155
Cambridge Investment Research Advisors
Iowa
$297K +$875 +31 +0.3%
AAM
156
Aureus Asset Management
Massachusetts
$280K +$282K +10,000 New
CCM
157
Cobalt Capital Management
New Jersey
$280K +$282K +10,000 New
GF
158
Gabelli Funds
New York
$280K +$282K +10,000 New
LCM
159
Landscape Capital Management
New Jersey
$278K +$281K +9,941 New
AQR Capital Management
160
AQR Capital Management
Connecticut
$272K +$21.4K +757 +8%
CGH
161
Crossmark Global Holdings
Texas
$267K +$4.41K +156 +2%
State of Wisconsin Investment Board
162
State of Wisconsin Investment Board
Wisconsin
$266K -$279K -9,867 -51%
QCM
163
Quantinno Capital Management
New York
$262K +$508 +18 +0.2%
HC
164
Henshaw Capital
Massachusetts
$262K +$264K +9,347 New
Commonwealth Equity Services
165
Commonwealth Equity Services
Massachusetts
$258K +$6.27K +222 +2%
Pathstone Holdings
166
Pathstone Holdings
New Jersey
$257K -$12.1K -427 -4%
XSC
167
X-Square Capital
Puerto Rico
$250K +$252K +8,918 New
NEI
168
Northwest & Ethical Investments
Ontario, Canada
$249K +$251K +8,900 New
X
169
Xponance
Pennsylvania
$249K +$251K +8,877 New
Corient Private Wealth
170
Corient Private Wealth
Florida
$237K +$239K +8,456 New
AFG
171
Atomi Financial Group
New York
$234K +$236K +8,354 New
Wolverine Trading
172
Wolverine Trading
Illinois
$233K +$239K +8,459 New
CIBC Asset Management
173
CIBC Asset Management
Ontario, Canada
$231K +$233K +8,257 New
First Trust Advisors
174
First Trust Advisors
Illinois
$212K +$214K +7,578 New
VPIM
175
Vanguard Personalized Indexing Management
California
$206K +$208K +7,372 New

RXO Hedge Fund Activity: Q3 2024 in Review

280 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in RXO (RXO) for Q3 2024, worth a combined $4.59B — up 46% from $3.14B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new RXO positions and 22 closed out — a net gain of 39 holders — while 106 added to existing stakes and 55 trimmed.

The largest buyer was Orbis Allan Gray, adding an estimated $304M. The largest seller was Frontier Capital Management, cutting an estimated $21.1M.

  • 280 institutional investors held RXO (RXO) as of Q3 2024, up from 242 in Q2 2024.
  • Funds reported $4.59B of RXO stock for Q3 2024, up 46% quarter-over-quarter.
  • 61 funds opened new RXO positions in Q3 2024 and 22 closed out, a net change of +39 holders.
  • The largest RXO buyer in Q3 2024 was Orbis Allan Gray, an estimated $304M added.
  • The largest RXO seller in Q3 2024 was Frontier Capital Management, an estimated $21.1M sold.

Based on aggregated 13F filings for Q3 2024.